USFDA approves Novartis Pluvicto to treat prostrate cancer
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
Data to establish the safety profile and human dose of vaccine candidate
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
The first-of-its-kind unique centre will increase access to preventive & primary care
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia
Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now
Subscribe To Our Newsletter & Stay Updated